Please check your internet connection and try again.
# Ferrous Ascorbate
## Overview
Ferrous ascorbate is a chelated form of iron consisting of iron (Fe2+) and ascorbic acid. The presence of ascorbic acid facilitates the reduction of ferric iron to ferrous iron, enhancing solubility and bioavailability, particularly in the alkaline environment of the duodenum.
## Primary Indications
Treatment and prevention of iron deficiency anemia (IDA) and latent iron deficiency.
## Adult Dosing
* **Treatment of IDA:** 100 mg (elemental iron) orally once or twice daily. Duration depends on hemoglobin normalization and iron store replenishment (typically 3–6 months).
* **Prophylaxis:** 50–100 mg daily or as determined by local protocol/physician preference based on iron status.
## Pediatric Dosing
* **Treatment of IDA:** 3–6 mg/kg/day of elemental iron, divided into 1–3 doses.
* *Note:* Dosing must be calculated based specifically on the elemental iron content per milliliter or tablet. Verify the salt-to-elemental ratio as formulations vary widely.
## Dose Adjustments
* **Renal Impairment:** No specific adjustment required; however, monitor closely in patients with chronic kidney disease (CKD) who may require intravenous iron if oral formulations prove ineffective due to elevated hepcidin levels.
* **Hepatic Impairment:** No specific adjustment required.
## Contraindications
* Hypersensitivity to iron or ascorbic acid.
* Hemochromatosis, hemosiderosis, or hemolytic anemia (unless concurrent iron deficiency is confirmed).
* Presence of active gastrointestinal ulcers or inflammatory bowel disease (may exacerbate symptoms).
* Repeated blood transfusions.
## Adverse Effects
* **Gastrointestinal:** Epigastric pain, nausea, vomiting, constipation, or diarrhea.
* **Stool changes:** Dark/black stools (expected and harmless).
* **Systemic:** Rare occurrences of allergic reactions (e.g., rash, pruritus).
## Key Drug Interactions
* **Levodopa/Methyldopa:** Iron may reduce absorption.
* **Quinolones/Tetracyclines:** Reduced absorption of antibiotics due to chelation; separate administration by at least 2 hours before or 4 hours after iron.
* **Antacids/PPIs/H2 Blockers:** Elevating gastric pH significantly impairs iron absorption; avoid concurrent use.
* **Calcium/Dairy:** Concurrent intake reduces iron absorption.
## Monitoring
* **Efficacy:** Hemoglobin and reticulocyte count (expected rise in 1–2 weeks).
* **Safety:** Monitor for GI intolerance.
* **Iron Studies:** Assess ferritin and transferrin saturation after 3 months of therapy to ensure adequate store repletion.
## Clinical Pearls
* **Bioavailability:** Best absorbed on an empty stomach; however, if GI side effects are limiting, administration with food may improve tolerability, albeit with reduced absorption.
* **Ascorbic Acid Synergy:** Unlike standard ferrous sulfate, the integrated ratio of ascorbic acid in ferrous ascorbate aids acidity in the microenvironment, potentially allowing for better absorption in patients with achlorhydria.
* **Toxicity:** Iron is highly toxic in overdose, especially in children. Keep packaging secure and out of reach.
***
**Educational Disclaimer:** This information is for educational purposes only. Dosing, contraindications, and interaction profiles can vary by product formulation and regional guidelines. Always verify current prescribing information, local hospital protocols, and patient-specific factors before clinical administration.
